These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 33226555)
1. Comparison of community illicit drug use in 11 cities of Turkey through wastewater-based epidemiology. Daglioglu N; Guzel EY; Atasoy A; Gören İE Environ Sci Pollut Res Int; 2021 Mar; 28(12):15076-15089. PubMed ID: 33226555 [TBL] [Abstract][Full Text] [Related]
2. Assessment of illicit drugs in wastewater and estimation of drugs of abuse in Adana Province, Turkey. Daglioglu N; Guzel EY; Kilercioglu S Forensic Sci Int; 2019 Jan; 294():132-139. PubMed ID: 30529037 [TBL] [Abstract][Full Text] [Related]
3. Spatial variations in the consumption of illicit stimulant drugs across Australia: A nationwide application of wastewater-based epidemiology. Lai FY; O'Brien J; Bruno R; Hall W; Prichard J; Kirkbride P; Gartner C; Thai P; Carter S; Lloyd B; Burns L; Mueller J Sci Total Environ; 2016 Oct; 568():810-818. PubMed ID: 27267725 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of spatial and temporal changes in illicit drug use in the Taipei metropolitan area via wastewater-based epidemiology. Lin HH; Wang YH; Liu JIWW; Hsieh MC; Huang SJ; Lien E; Huang LW; Lin AY Sci Total Environ; 2024 Jul; 934():173313. PubMed ID: 38761952 [TBL] [Abstract][Full Text] [Related]
5. Illicit drug consumption estimated using wastewater analysis and compared by settlement size in New Zealand. Chappell A; Armstrong B; Jay E; Phung K; McCormick S; Grigg S; Waite B Sci Total Environ; 2022 Oct; 843():156956. PubMed ID: 35760179 [TBL] [Abstract][Full Text] [Related]
6. Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study. Cruz-Cruz C; Yargeau V; Vidaña-Perez D; Schilmann A; Pineda MA; Lobato M; Hernández-Avila M; Villatoro JA; Barrientos-Gutierrez T Int J Drug Policy; 2021 Feb; 88():103027. PubMed ID: 33212372 [TBL] [Abstract][Full Text] [Related]
7. Consumption of common illicit drugs in twenty-one cities in southwest China through wastewater analysis. Wang H; Xu B; Yang L; Huo T; Bai D; An Q; Li X Sci Total Environ; 2022 Dec; 851(Pt 1):158105. PubMed ID: 35987225 [TBL] [Abstract][Full Text] [Related]
8. Wastewater-based monitoring of illicit drug consumption in Istanbul: Preliminary results from two districts. Mercan S; Kuloglu M; Tekin T; Turkmen Z; Dogru AO; Safran AN; Acikkol M; Asicioglu F Sci Total Environ; 2019 Mar; 656():231-238. PubMed ID: 30504023 [TBL] [Abstract][Full Text] [Related]
9. Estimation of illicit drug use in the main cities of Colombia by means of urban wastewater analysis. Bijlsma L; Botero-Coy AM; Rincón RJ; Peñuela GA; Hernández F Sci Total Environ; 2016 Sep; 565():984-993. PubMed ID: 27246161 [TBL] [Abstract][Full Text] [Related]
10. Monitoring geographical differences in illicit drugs, alcohol, and tobacco consumption via wastewater-based epidemiology: Six major cities in Turkey. Kuloglu Genc M; Mercan S; Yayla M; Tekin Bulbul T; Adioren C; Simsek SZ; Asicioglu F Sci Total Environ; 2021 Nov; 797():149156. PubMed ID: 34346379 [TBL] [Abstract][Full Text] [Related]
11. Illicit drug use in Reykjavik by wastewater-based epidemiology. Löve ASC; Ásgrímsson V; Ólafsdóttir K Sci Total Environ; 2022 Jan; 803():149795. PubMed ID: 34482138 [TBL] [Abstract][Full Text] [Related]
12. Wastewater-based assessment of regional and temporal consumption patterns of illicit drugs and therapeutic opioids in Croatia. Krizman I; Senta I; Ahel M; Terzic S Sci Total Environ; 2016 Oct; 566-567():454-462. PubMed ID: 27232972 [TBL] [Abstract][Full Text] [Related]
13. Key Interpretation Challenges for Wastewater-Based Epidemiology of Illicit Drugs: A Norwegian Three-City Case Study. Bretteville-Jensen AL; Amundsen EJ; Mounteney J Eur Addict Res; 2022; 28(6):436-445. PubMed ID: 36137511 [TBL] [Abstract][Full Text] [Related]
14. Investigation of temporal illicit drugs, alcohol and tobacco trends in Istanbul city: Wastewater analysis of 14 treatment plants. Asicioglu F; Kuloglu Genc M; Tekin Bulbul T; Yayla M; Simsek SZ; Adioren C; Mercan S Water Res; 2021 Feb; 190():116729. PubMed ID: 33341037 [TBL] [Abstract][Full Text] [Related]
15. Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic. Psichoudaki M; Mina T; Savvidou M; Mina C; Michael C; Fatta-Kassinos D Sci Total Environ; 2023 Jan; 854():158747. PubMed ID: 36108831 [TBL] [Abstract][Full Text] [Related]
16. Sewage analysis as an alternative tool for assessing drug of abuse and new psychoactive substances in Tunisia. Moslah B; Smaoui O; Nouioui MA; Araoud M; Chaouali N; Laribi M; Amira D; Ben Salah N; Hedhili A Forensic Sci Int; 2023 Jun; 347():111672. PubMed ID: 37023613 [TBL] [Abstract][Full Text] [Related]
17. Consumption of illicit drugs and benzodiazepines in six Spanish cities during different periods of the COVID-19 pandemic. Gracia-Lor E; Pérez-Valenciano A; De Oro-Carretero P; Ramírez-García L; Sanz-Landaluze J; Martín-Gutiérrez MJ Sci Total Environ; 2024 Jul; 935():173356. PubMed ID: 38772484 [TBL] [Abstract][Full Text] [Related]
18. Long-term monitoring of drug consumption patterns in a large-sized European city using wastewater-based epidemiology: Comparison of two sampling schemes for the assessment of multiannual trends. Krizman-Matasic I; Senta I; Kostanjevecki P; Ahel M; Terzic S Sci Total Environ; 2019 Jan; 647():474-485. PubMed ID: 30086499 [TBL] [Abstract][Full Text] [Related]
19. Dilute-and-shoot approach for the high-throughput LC-MS/MS determination of illicit drugs in the field of wastewater-based epidemiology. Gracia-Marín E; Hernández F; Ibáñez M; Bijlsma L Water Res; 2024 Aug; 259():121864. PubMed ID: 38852386 [TBL] [Abstract][Full Text] [Related]
20. Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring. González-Mariño I; Baz-Lomba JA; Alygizakis NA; Andrés-Costa MJ; Bade R; Bannwarth A; Barron LP; Been F; Benaglia L; Berset JD; Bijlsma L; Bodík I; Brenner A; Brock AL; Burgard DA; Castrignanò E; Celma A; Christophoridis CE; Covaci A; Delémont O; de Voogt P; Devault DA; Dias MJ; Emke E; Esseiva P; Fatta-Kassinos D; Fedorova G; Fytianos K; Gerber C; Grabic R; Gracia-Lor E; Grüner S; Gunnar T; Hapeshi E; Heath E; Helm B; Hernández F; Kankaanpaa A; Karolak S; Kasprzyk-Hordern B; Krizman-Matasic I; Lai FY; Lechowicz W; Lopes A; López de Alda M; López-García E; Löve ASC; Mastroianni N; McEneff GL; Montes R; Munro K; Nefau T; Oberacher H; O'Brien JW; Oertel R; Olafsdottir K; Picó Y; Plósz BG; Polesel F; Postigo C; Quintana JB; Ramin P; Reid MJ; Rice J; Rodil R; Salgueiro-González N; Schubert S; Senta I; Simões SM; Sremacki MM; Styszko K; Terzic S; Thomaidis NS; Thomas KV; Tscharke BJ; Udrisard R; van Nuijs ALN; Yargeau V; Zuccato E; Castiglioni S; Ort C Addiction; 2020 Jan; 115(1):109-120. PubMed ID: 31642141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]